Efficient and advanced temperature monitoring, control and response can be achieved by pharmaceutical companies through automative processes.
Pfizer has stopped its research on the possible cure for Parkinson's and Alzheimer's diseases.
Centrexion Therapeutics will allot the funding to the next phase of its CNTX-4975 drug.
The healthcare industry in the U.S. is also booming with mergers and acquisitions.